Acalabrutinib monotherapy in patients with relapsed/ refractory chronic lymphocytic leukemia: Updated phase 2 results

John C. Byrd, William G. Wierda, Anna Schuh, Stephen Devereux, Jorge M. Chaves, Jennifer R. Brown, Peter Hillmen, Peter Martin, Farrukh T. Awan, Deborah M. Stephens, Paolo Ghia, Jacqueline Barrientos, John M. Pagel, Jennifer A. Woyach, Kathleen Burke, Todd Covey, Michael Gulrajani, Ahmed Hamdy, Raquel Izumi, Melanie M. FrigaultPriti Patel, Wayne Rothbaum, Min Hui Wang, Susan O'Brien, Richard R. Furman

Research output: Contribution to journalArticlepeer-review

122 Scopus citations

Fingerprint

Dive into the research topics of 'Acalabrutinib monotherapy in patients with relapsed/ refractory chronic lymphocytic leukemia: Updated phase 2 results'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry